|
시장보고서
상품코드
2110074
다중암 조기 검진(MCED) 시장(2026-2030년)Global Multi-Cancer Early Detection Market 2026-2030 |
||||||
세계의 다중암 조기 검진(MCED) 시장은 2025-2030년 15억 940만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 15.6%를 기록할 것으로 예측됩니다.
세계 다중암 조기 검진(MCED) 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 공급업체 분석을 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 암 유병률의 상승이 시장 성장을 가속화하고 있으며, 의료에 대한 인식 제고가 시장 성장을 가속하고 있고, 고령화의 진행에 의해 견인되고 있습니다.
본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 정보와 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석이 포함된 부문, 벤더 현황이 기재되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준연도 | 2025년 |
| 종료연도 | 2030년 |
| 조사 대상 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| YOY 2026 | 14.9% |
| CAGR | 15.6% |
| 증가액 | 15억 940만 달러 |
본 조사에서는 신제품 개발에 대한 집중이 향후 수년간 전 세계 다중암 조기 검진(MCED) 시장의 성장을 견인할 주요 요인 중 하나라고 규명하고 있습니다. 또한, 제휴 및 파트너십 증가가 시장 성장을 뒷받침하고 있으며, 암 진단 및 연구 분야로의 AI 도입은 시장에서 상당한 수요를 창출할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 유형별
제9장 시장 세분화 : 최종사용자별
제10장 시장 세분화 : 기술별
제11장 고객 현황
제12장 지역별 상황
제13장 성장 촉진요인, 과제 및 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
LSH 26.08.19The global multi-cancer early detection market is forecasted to grow by USD 1509.4 mn during 2025-2030, accelerating at a CAGR of 15.6% during the forecast period. The report on the global multi-cancer early detection market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer prevalence are accelerating market growth, increased healthcare awareness is expediting market growth, growth in aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 14.9% |
| CAGR | 15.6% |
| Incremental Value | $1509.4 mn |
Technavio's global multi-cancer early detection market is segmented as below:
By Type
- Gene panel
- LDT
- Liquid biopsy
- Others
By End-User
- Hospitals
- Diagnostic laboratories
- Others
By Technology
- Epigenomics
- Fragmentomics
- Genomics
- Proteomics
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the focus on new product development as one of the prime reasons driving the global multi-cancer early detection market growth during the next few years. Also, increase in collaborations and partnerships are augmenting market growth and integration of ai into cancer diagnosis and research will lead to sizable demand in the market.
The report on the global multi-cancer early detection market covers the following areas:
- Global multi-cancer early detection market sizing
- Global multi-cancer early detection market forecast
- Global multi-cancer early detection market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global multi-cancer early detection market vendors that include Advanced Medicine, Ajinomoto Co. Inc., Berry Genomics Co. Ltd., Burning Rock Biotech Ltd., Caris Life Sciences, Clearnote Health, Datar Cancer Genetics, Elypta AB, Eone Diagnomics Genome Center, Exact Sciences Corp., Gene Solutions, Genecast Biotechnology Co. Ltd., GRAIL Inc., Guardant Health Inc., IvyGene Labs, PredOmix Technologies Pvt Ltd, SeekIn Inc., Singlera Genomics Inc., StageZero Life Sciences Ltd., Zyagnum AG. Also, the global multi-cancer early detection market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Multi-Cancer Early Detection Market 2020 - 2024
- Historic Market Size - Data Table on Global Multi-Cancer Early Detection Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Multi-Cancer Early Detection Market
- 6.2 Impact of Geopolitical Conflicts on Global Multi-Cancer Early Detection Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Gene panel - Market size and forecast 2025-2030
- 8.4 LDT - Market size and forecast 2025-2030
- 8.5 Liquid biopsy - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2025-2030
- 9.4 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.5 Others - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 Epigenomics - Market size and forecast 2025-2030
- 10.4 Fragmentomics - Market size and forecast 2025-2030
- 10.5 Genomics - Market size and forecast 2025-2030
- 10.6 Proteomics - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Taiwan - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Israel - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Egypt - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising cancer prevalence are accelerating market growth
- Increased healthcare awareness is expediting market growth
- Growth in aging population
- 13.2 Market challenges
- Limited insurance coverage is degrading market growth
- High costs of MCED tests
- False positives and overdiagnosis
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Focus on new product development
- Increase in collaborations and partnerships are augmenting market growth
- Integration of AI into cancer diagnosis and research
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Ajinomoto Co. Inc.
- Ajinomoto Co. Inc. - Overview
- Ajinomoto Co. Inc. - Business segments
- Ajinomoto Co. Inc. - Key offerings
- Ajinomoto Co. Inc. - Segment focus
- SWOT
- 15.5 Berry Genomics Co. Ltd.
- Berry Genomics Co. Ltd. - Overview
- Berry Genomics Co. Ltd. - Business segments
- Berry Genomics Co. Ltd. - Key offerings
- Berry Genomics Co. Ltd. - Segment focus
- SWOT
- 15.6 Burning Rock Biotech Ltd.
- Burning Rock Biotech Ltd. - Overview
- Burning Rock Biotech Ltd. - Business segments
- Burning Rock Biotech Ltd. - Key offerings
- Burning Rock Biotech Ltd. - Segment focus
- SWOT
- 15.7 Caris Life Sciences
- Caris Life Sciences - Overview
- Caris Life Sciences - Product / Service
- Caris Life Sciences - Key offerings
- SWOT
- 15.8 Elypta AB
- Elypta AB - Overview
- Elypta AB - Product / Service
- Elypta AB - Key offerings
- SWOT
- 15.9 Exact Sciences Corp.
- Exact Sciences Corp. - Overview
- Exact Sciences Corp. - Product / Service
- Exact Sciences Corp. - Key offerings
- SWOT
- 15.10 Gene Solutions
- Gene Solutions - Overview
- Gene Solutions - Product / Service
- Gene Solutions - Key offerings
- SWOT
- 15.11 Genecast Biotechnology Co. Ltd.
- Genecast Biotechnology Co. Ltd. - Overview
- Genecast Biotechnology Co. Ltd. - Product / Service
- Genecast Biotechnology Co. Ltd. - Key offerings
- SWOT
- 15.12 GRAIL Inc.
- GRAIL Inc. - Overview
- GRAIL Inc. - Product / Service
- GRAIL Inc. - Key offerings
- SWOT
- 15.13 Guardant Health Inc.
- Guardant Health Inc. - Overview
- Guardant Health Inc. - Product / Service
- Guardant Health Inc. - Key offerings
- SWOT
- 15.14 IvyGene Labs
- IvyGene Labs - Overview
- IvyGene Labs - Product / Service
- IvyGene Labs - Key offerings
- SWOT
- 15.15 SeekIn Inc.
- SeekIn Inc. - Overview
- SeekIn Inc. - Product / Service
- SeekIn Inc. - Key offerings
- SWOT
- 15.16 Singlera Genomics Inc.
- Singlera Genomics Inc. - Overview
- Singlera Genomics Inc. - Product / Service
- Singlera Genomics Inc. - Key offerings
- SWOT
- 15.17 StageZero Life Sciences Ltd.
- StageZero Life Sciences Ltd. - Overview
- StageZero Life Sciences Ltd. - Product / Service
- StageZero Life Sciences Ltd. - Key offerings
- SWOT
- 15.18 Zyagnum AG
- Zyagnum AG - Overview
- Zyagnum AG - Product / Service
- Zyagnum AG - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
